Table of Contents Author Guidelines Submit a Manuscript
Bone Marrow Research
Volume 2011 (2011), Article ID 579268, 3 pages
http://dx.doi.org/10.1155/2011/579268
Research Article

Hyperbaric Oxygen Therapy as a Sole Agent Is Not Immunosuppressant in a Highly Immunogenic Mouse Model

1Division of Haematology/Oncology/BMT, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, Canada M5G 1X8
2Division of Immunology and Allergy, The Hospital for Sick Children, University of Toronto, ON, Canada M5G 1X8
3Hyperbaric Medicine Unit, University Health Network, Toronto General Hospital, Faculty of Medicine, University of Toronto, ON, Canada M5G 2C4
4Animal Facilities, Faculty of Dentistry, University of Toronto, Toronto, ON, Canada M5G 1G6
5Oral and Maxillofacial Surgery, University of Toronto, Toronto, ON, Canada M5G 1G6
6Tissue Engineering, Regea Institute for Regenerative Medicine, University of Tampere, 33520 Tampere, Finland

Received 7 May 2010; Accepted 18 June 2010

Academic Editor: Axel R. Zander

Copyright © 2011 Adam Gassas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. V. Granowitz, E. J. Skulsky, R. M. Benson et al., “Exposure to increased pressure or hyperbaric oxygen suppresses interferon-γ secretion in whole blood cultures of healthy humans,” Undersea and Hyperbaric Medicine, vol. 29, no. 3, pp. 216–225, 2002. View at Google Scholar · View at Scopus
  2. R. M. Benson, L. M. Minter, B. A. Osborne, and E. V. Granowitz, “Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages,” Clinical and Experimental Immunology, vol. 134, no. 1, pp. 57–62, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Bitterman, H. Bitterman, A. Kinarty, Y. Melamed, and N. Lahat, “Effect of a single exposure to hyperbaric oxygen on blood mononuclear cells in human subjects,” Undersea & Hyperbaric Medicine, vol. 20, no. 3, pp. 197–204, 1993. View at Google Scholar · View at Scopus
  4. M. A. Gadd, D. S. McClellan, T. S. Neuman, and J. F. Hansbrough, “Effect of hyperbaric oxygen on murine neutrophil and T-lymphocyte functions,” Critical Care Medicine, vol. 18, no. 9, pp. 974–979, 1990. View at Google Scholar · View at Scopus
  5. W. D. Won, H. C. Ross, and E. F. Deig, “Influence of cold or hyperbaric helium oxygen environments on mouse response to a respiratory viral infection,” Aviation Space and Environmental Medicine, vol. 47, no. 7, pp. 704–707, 1976. View at Google Scholar · View at Scopus
  6. W. D. Won and H. C. Ross, “Catecholamine and phagocytic responses in infected mice exposed to hyperbaric helium oxygen atmospheres,” Aviation Space and Environmental Medicine, vol. 46, no. 2, pp. 191–193, 1975. View at Google Scholar · View at Scopus
  7. B. B. Jacobs, C. A. Thuning, M. R. Sacksteder, and J. Warren, “Extended skin allograft survival in mice during prolonged exposure to hyperbaric oxygen,” Transplantation, vol. 28, no. 1, pp. 70–72, 1979. View at Google Scholar · View at Scopus
  8. D. Erdmann, A. C. Roth, J. Hussmann et al., “Skin allograft rejection and hyperbaric oxygen treatment in immune-histoincompatible mice,” Undersea & Hyperbaric Medicine, vol. 22, no. 4, pp. 395–399, 1995. View at Google Scholar · View at Scopus
  9. D. Erdmann, A. C. Roth, J. Hussmann et al., “Hyperbaric oxygen and cyclosporine as a combined treatment regimen to prevent skin allograft rejection in immunohistoincompatible mice,” Annals of Plastic Surgery, vol. 36, no. 3, pp. 304–308, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Brenner, R. J. Shephard, and P. N. Shek, “Immune function in hyperbaric environments, diving, and decompression,” Undersea and Hyperbaric Medicine, vol. 26, no. 1, pp. 27–36, 1999. View at Google Scholar · View at Scopus
  11. A. Ersson, M. Walles, K. Ohlsson, and A. Ekholm, “Chronic hyperbaric exposure activates proinflammatory mediators in humans,” Journal of Applied Physiology, vol. 92, no. 6, pp. 2375–2380, 2002. View at Google Scholar · View at Scopus
  12. C. M. Muth and E. S. Shank, “Gas embolism,” New England Journal of Medicine, vol. 342, no. 7, pp. 476–482, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. R. M. Leach, P. J. Rees, and P. Wilmshurst, “Hyperbaric oxygen therapy,” British Medical Journal, vol. 317, no. 7166, pp. 1140–1143, 1998. View at Google Scholar · View at Scopus
  14. S. Enoch, J. E. Grey, and K. G. Harding, “ABC of wound healing. Non-surgical and drug treatments,” British Medical Journal, vol. 332, pp. 900–903, 2006. View at Google Scholar
  15. A. L. Gill and C. N. A. Bell, “Hyperbaric oxygen: its uses, mechanisms of action and outcomes,” QJM, vol. 97, no. 7, pp. 385–395, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Calzia, S. Öter, C.-M. Muth, and P. Radermacher, “Evolving career of hyperbaric oxygen in sepsis: from augmentation of oxygen delivery to the modulation of the immune response,” Critical Care Medicine, vol. 34, no. 10, pp. 2693–2695, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Öter, P. Radermacher, and M. Matejovic, “Can (hyperbaric) oxygen turn off the motor of multiorgan dysfunction?” Intensive Care Medicine, vol. 32, no. 11, pp. 1694–1696, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. C.-M. Muth, P. Radermacher, and S. Cuzzocrea, “Hyperbaric oxygen and sepsis: time to recognize,” Intensive Care Medicine, vol. 31, no. 9, pp. 1150–1152, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Hadidi, Z. Chen, J. Phillips, K. Yu, and R. M. Gorczynski, “Antisense deoxyoligonucleotides or antibodies to murine MD-1 inhibit rejection of allogeneic and xenogeneic skin grafts in C3H mice,” Transplantation, vol. 73, no. 11, pp. 1771–1779, 2002. View at Google Scholar · View at Scopus
  20. B. B. Jacobs, C. A. Thuning, M. R. Sacksteder, and J. Warren, “Extended skin allograft survival in mice during prolonged exposure to hyperbaric oxygen,” Transplantation, vol. 28, no. 1, pp. 70–72, 1979. View at Google Scholar · View at Scopus
  21. D. Erdmann, A. C. Roth, J. Hussmann et al., “Skin allograft rejection and hyperbaric oxygen treatment in immune-histoincompatible mice,” Undersea & Hyperbaric Medicine., vol. 22, no. 4, pp. 395–399, 1995. View at Google Scholar · View at Scopus
  22. D. Erdmann, A. C. Roth, J. Hussmann et al., “Hyperbaric oxygen and cyclosporine as a combined treatment regimen to prevent skin allograft rejection in immunohistoincompatible mice,” Annals of Plastic Surgery, vol. 36, no. 3, pp. 304–308, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. W. A. Zamboni, A. C. Roth, R. C. Russell, and E. C. Smoot, “The effect of hyperbaric oxygen on reperfusion of ischemic axial skin flaps: a laser Doppler analysis,” Annals of Plastic Surgery, vol. 28, no. 4, pp. 339–341, 1992. View at Google Scholar · View at Scopus
  24. S. Bayati, R. C. Russell, and A. C. Roth, “Stimulation of angiogenesis to improve the viability of prefabricated flaps,” Plastic and Reconstructive Surgery, vol. 101, no. 5, pp. 1290–1295, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Renner, S. D. McClane, E. Early, P. Bell, and B. Shaw, “Enhancement of auricular composite graft survival with hyperbaric oxygen therapy,” Archives of Facial Plastic Surgery, vol. 4, no. 2, pp. 102–104, 2002. View at Google Scholar · View at Scopus
  26. L. S. Nichter, D. T. Morwood, G. S. Williams, and R. J. Spence, “Expanding the limits of composite grafting: a case report of successful nose replantation assisted by hyperbaric oxygen therapy,” Plastic and Reconstructive Surgery, vol. 87, no. 2, pp. 337–340, 1991. View at Google Scholar · View at Scopus
  27. J. H. Rapley, W. T. Lawrence, and P. D. Witt, “Composite grafting and hyperbaric oxygen therapy in pediatric nasal tip reconstruction after avulsive dog-bite injury,” Annals of Plastic Surgery, vol. 46, no. 4, pp. 434–438, 2001. View at Google Scholar · View at Scopus